A nanoscale optical device has been developed that allows independent control over the intensity and phase of light. By ...

Digital transformation isn’t failing because of poor tech. It’s failing because of poor thinking behind its utilisation. Every boardroom knows the script: “We need to go digital, we need to be more ...

Actor Christopher Biggins has revealed he is using weight loss jabs as he needed to lose weight after having surgery on his knee. Porridge star Biggins, 76, said he is taking Mounjaro, which is made ...

Pithori Amavasya, which will be observed this year on August 22, 2025, carries profound spiritual weight. Known as a time to honour the Divine Mother and seek blessings for children, prosperity, and ...

Missense variants in the O-GlcNAc transferase ( OGT) gene have recently been shown to segregate with a syndromic form of intellectual disability (OGT-ID), underscoring the importance of protein ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...

Los Angeles Lakers are eyeing Brooklyn Nets center Nic Claxton. A trade proposal involves Lakers sending Rui Hachimura and draft picks to the Nets. Lakers want Claxton for defense and rebounding. Nets ...

September brings Aries a much-needed balance between ambition and reflection. Your usual fiery energy finds purpose when paired with patience this month. Work-related travel or short-term projects ...

22:43, Sat, Aug 30, 2025 Updated: 22:47, Sat, Aug 30, 2025 A £1.65 million transformation is set to “breathe new life” into a UK city's high street. Work on Dunfermline’s high street will start next ...

Two male and two female right-handed volunteer psychology students (aged 20–24) served as subjects. They wore left–right reversing spectacles continuously for 39 (two males) or 35 (two females) days.

A cholesterol-busting jab that is administered twice a year has the potential to transform heart care, according to its developer. It comes as new trial data suggests Leqvio, also known as inclisiran ...